NORTHERN TRUST CORP - ZOMEDICA PHARMACEUTICALS COR ownership

ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 29 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ZOMEDICA PHARMACEUTICALS COR
ValueSharesWeighting
Q3 2020$93,000
-44.3%
842,203
+20.3%
0.00%
Q2 2020$167,000
+122.7%
700,163
+114.4%
0.00%
Q2 2019$75,000
-39.0%
326,583
-6.8%
0.00%
Q1 2019$123,000
-71.6%
350,568
-0.4%
0.00%
Q4 2018$433,000
-34.4%
351,842
-0.4%
0.00%
Q3 2018$660,000
+358.3%
353,334
+450.2%
0.00%
Q2 2018$144,00064,2190.00%
Other shareholders
ZOMEDICA PHARMACEUTICALS COR shareholders Q2 2020
NameSharesValueWeighting ↓
Cambridge Investment Research Advisors, Inc. 12,079,080$27,178,0000.29%
jvl associates llc 58,500$132,0000.13%
Sigma Planning Corp 27,500$62,0000.00%
NORTHWEST WEALTH MANAGEMENT, LLC 280$1,0000.00%
Tower Research Capital LLC (TRC) 4,158$9,0000.00%
Ameritas Investment Partners, Inc. 2,890$7,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 60,388$136,0000.00%
UBS Group AG 9,495$21,0000.00%
RHUMBLINE ADVISERS 31,685$71,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1,290$2,902,0000.00%
View complete list of ZOMEDICA PHARMACEUTICALS COR shareholders